Scholarly Index
Robin Kate Kelley
UCSF Helen Diller Family Comprehensive Cancer Center; 75,633 total citations; 370 total publications; best world rank #11
UCSF Helen Diller Family Comprehensive Cancer Center
75,633Total citations
370Total publications
91H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 63 | US 29 | 99.68 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 66 | US 35 | 99.56 |
| Cancer Mechanisms and Therapy | Lifetime | 43 | US 24 | 99.26 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 170 | US 94 | 99.43 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 465 | US 243 | 98.94 |
| Colorectal Cancer Treatments and Studies | Lifetime | 499 | US 216 | 98.50 |
| Ferroptosis and cancer prognosis | Lifetime | 675 | US 154 | 93.96 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 11 | US 5 | 99.73 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 17 | US 8 | 99.68 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 110 | US 38 | 98.79 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 295 | US 117 | 98.86 |
| Cancer Mechanisms and Therapy | 2021-2025 | 38 | US 6 | 96.80 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 268 | US 91 | 96.54 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 353 | US 73 | 94.27 |
| Fibroblast Growth Factor Research | 2021-2025 | 119 | US 45 | 86.47 |
| Liver physiology and pathology | 2021-2025 | 540 | US 83 | 75.72 |